Lifecore Biomedical Affirms FY2026 Sales Guidance of $74.000M-$76.000M vs $131.882M Est
Benzinga Newsdesk 12 months ago
NewsGuidance
Lifecore Biomedical (NASDAQ:LFCR) affirms FY2026 sales outlook from $74.000 million-$76.000 million to $74.000 million-$76.000 million vs $131.882 million estimate.
Lifecore Biomedical (NASDAQ:LFCR) affirms FY2026 sales outlook from $74.000 million-$76.000 million to $74.000 million-$76.000 million vs $131.882 million estimate.